Search the Newsreel

Ihuman Inc (IH) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Ihuman Inc (IH), listing major institutional shareholders such as Morgan Stanley, Citadel Advisors, and Acadian Asset Management, along with their respective holdings and proportions. It also presents a historical overview of institutional shareholding from 2023Q4 to 2026Q1, …

Price to sales forward of Humacyte, Inc. – NASDAQ:HUMAW

This article from TradingView provides financial information for Humacyte, Inc. (NASDAQ: HUMAW), specifically focusing on its price-to-sales forward metric. The content highlights a specific period, value, and change percentage for this financial indicator, framed within a market data and analysis platform context.

Ihuman Inc (IH) Cash Flow

This article provides an overview of Ihuman Inc's cash flow statement, detailing its operating, investing, and financing cash flows. It highlights that Ihuman Inc generated $7.44M in operating cash flow in fiscal 2025 and spent $710.79K on capital expenditures in the most recent quarter. …

Humana Inc. Revenue Breakdown – NYSE:HUM

Humana Inc.'s revenue reached $129.66 billion USD last year, primarily driven by its Insurance segment which generated $124.56 billion USD. The majority of this revenue, $129.66 billion USD, originated from operations within the United States. This indicates a strong performance in its core insurance …

Humana Inc. stock underperforms Friday when compared to competitors

Humana Inc. (HUM) shares fell 1.31% to $389.32 on Friday, despite a positive trading session for the broader market, with both the S&P 500 Index and the Dow Jones Industrial Average seeing gains. This marks the third consecutive day of losses for the stock.

Can Humana Beat Q2 Earnings Estimates on Growing Premiums?

Humana (HUM) is expected to announce its Q2 2026 earnings on July 29, with analysts predicting a slight year-over-year decrease in EPS but significant revenue growth due to increasing premiums. The company has a positive Earnings ESP and a Zacks Rank #1, suggesting a …

KBC Group NV Trims Holdings in Humana Inc. $HUM

KBC Group NV reduced its stake in Humana Inc. by 27.4% in the first quarter, selling 11,584 shares and retaining 30,718 shares valued at $5.33 million. Despite analyst caution with an average "Hold" rating and a $327.17 price target, Humana reported strong Q1 earnings …

Kopernik Global Investors LLC Takes Position in Humana Inc. $HUM

Kopernik Global Investors LLC has acquired a new stake in Humana Inc. (NYSE:HUM) during the first quarter, purchasing 113,385 shares valued at approximately $19.66 million. This investment positions Humana as the 21st biggest holding for Kopernik, representing about 1.4% of its portfolio. Other institutional …

SEB Asset Management AB Purchases Shares of 24,228 Humana Inc. $HUM

SEB Asset Management AB acquired 24,228 shares of Humana Inc. (NYSE:HUM) in the first quarter, valued at approximately $4.2 million. Other institutional investors like Swiss National Bank and Watershed Asset Management also adjusted their positions in the insurance provider. Humana reported strong Q1 earnings, …

Humana Inc (HUM) extends 12-week advance to 86.3%

The healthcare-plan stock is still trending higher, though relative strength remains moderate rather than emphatic.

Humana 401(k) Forfeiture Challenge Paused for Appeals Court Say

A lawsuit concerning how Humana Inc. manages forfeited contributions in its 401(k) plan has been put on hold. The pause is awaiting a decision from the US Court of Appeals for the Sixth Circuit in a related case, Donelson v. Meijer Inc., which is …

Humana (HUM) Expected to Beat Earnings Estimates: Should You Buy?

Wall Street expects a year-over-year decline in earnings on higher revenues when Humana (HUM) reports results for the quarter ended June 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock …

Meeder Asset Management Inc. Sells 5,762 Shares of Humana Inc. $HUM

Meeder Asset Management Inc. significantly reduced its holdings in Humana Inc. (NYSE:HUM) by 79.6% in the first quarter, selling 5,762 shares and retaining 1,476 shares valued at $256,000. Other institutional investors, however, increased their positions in Humana. The insurance provider reported strong first-quarter earnings, …

Humana Inc. $HUM Shares Sold by California Public Employees Retirement System

California Public Employees Retirement System reduced its stake in Humana Inc. by 24.4% in the first quarter, selling 55,174 shares and owning approximately $29.68 million worth of the company's stock. Despite some institutional selling, other firms increased their holdings in Humana. The article also …

Authum Investment Confirms Income Tax Raid Ongoing Since 20 July

Authum Investment Q1 net profit rises 18.5% to ₹1,114.81 crore

Humacyte, Inc. (HUMA) Beats Stock Market Upswing: What Investors Need to Know

Humacyte, Inc. (HUMA) saw its stock close at $0.67, a 2.22% increase, outperforming the S&P 500's daily gain, despite a 21.82% drop over the past month. Analysts project a significant increase in EPS and revenue for the upcoming release and the full year, with …

Humana (HUM) is a Great Momentum Stock: Should You Buy?

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; …

Humacyte, Inc. (HUMA) Suffers a Larger Drop Than the General Market: Key Insights

Humacyte, Inc. (HUMA) experienced a larger drop than the general market, closing down 1.28% against a backdrop of slight S&P 500 and Nasdaq depreciation, and a 0.59% Dow downswing. The company's stock has fallen 28.09% in the past month, underperforming the Medical sector and …

Humana Inc. $HUM Shares Sold by Bank of New York Mellon Corp

Bank of New York Mellon Corp significantly reduced its stake in Humana Inc. (NYSE:HUM) by 70.6% in the first quarter, selling 1,479,679 shares and now owning 614,891 shares valued at $106.6 million. Despite this, other institutional investors have either increased or initiated positions in …

Authum Investment & Infrastructure consolidated net profit rises 17.76% in the June 2026 quarter

Humana Inc (HUM) pushes 12-week rebound to 86.3%

The healthcare-plans stock is trading with an active trend, though relative strength remains moderate rather than emphatic.

UNC Health, Humana End 340B Drug Underpayment Fight

UNC Health has settled two lawsuits against Humana, alleging underpayment for drugs acquired through the federal 340B discount program. The settlement was noted in North Carolina federal court, indicating the resolution of the dispute concerning the drug pricing.

Heartland Advisors Inc. Sells 2,535 Shares of Humana Inc. $HUM

Heartland Advisors Inc. reduced its stake in Humana Inc. (NYSE:HUM) by 10.6% in the first quarter, selling 2,535 shares and retaining 21,353 shares valued at $3.7 million. Other institutional investors like Watershed Asset Management and Hartford Funds Management Co LLC also made significant moves …

Bronstein, Gewirtz & Grossman, LLC Encourages Humana Inc. (HUM) Investors to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of investors who purchased Humana Inc. (NYSE:HUM) securities prior to June 27, 2022, and continue to hold them. The investigation focuses on whether Humana and its officers engaged in corporate wrongdoing. The firm …

Did Rising Analyst Earnings Estimates and Zacks Rank Upgrade Just Shift Humana's (HUM) Investment Narrative?

Earlier this week, Humana reported that analysts have increasingly raised their earnings estimates, with the stock's analyst rating improving to a Zacks Rank #1 (Strong Buy) and sentiment strengthening around its near-term outlook. The strong agreement among analysts on higher profit expectations, especially within …

Watershed Asset Management L.L.C. Takes $474,000 Position in Humana Inc. $HUM

Watershed Asset Management L.L.C. recently initiated a new position in Humana Inc. (NYSE:HUM), purchasing 2,735 shares valued at approximately $474,000 during the first quarter. This aligns with a broader trend of institutional investment, as institutions now own 92.38% of Humana's stock. The insurance provider …

Humana stock hits 52-week high at 424.0 USD By Investing.com

Humana Inc. (NYSE: HUM) stock has reached a new 52-week high of $424, marking an 82.41% increase over the past year and indicating strong investor confidence. Despite trading near its peak with an RSI suggesting it's overbought, InvestingPro analysis indicates the stock may still …

Agreement between Wexner Medical Center, Humana set to end in October

This article reports that the agreement between Wexner Medical Center and Humana is scheduled to terminate in October. No further details are provided regarding the implications or reasons for this termination.

Humana (NYSE:HUM) Upgraded by Zacks Research to "Strong-Buy" Rating

Zacks Research has upgraded Humana (NYSE:HUM) to a "strong-buy" rating from "hold," despite the broader analyst consensus remaining at "Hold." This upgrade follows Humana's latest earnings report, which exceeded expectations with EPS of $10.31 and revenue of $39.65 billion, a 23.5% year-over-year increase. The …

Indian Hume Pipe Company Marks 100 Years, Reports FY2025-26 Financial Results and Declares Special Centennial Dividend

Humana Inc (HUM) rebound builds in weekly context

The healthcare-plan stock’s latest weekly move adds to a strong three-month recovery, though participation remains lighter than its recent average.

Indian Hume Pipe Company Share Price Target 2026: Bull Case Rs 43

Indian Hume Pipe Wins ₹738 Crore Rajasthan Water Project

Indian Hume Pipe Secures ₹738.61 Cr Rajasthan Water Project Powering 24-Month Growth

Humana Inc (HUM) puts 115.8% 12-week rebound in focus

The managed-care stock is recovering quickly, though confirmation outside price remains mixed.